Written by : Saloni Tyagi
April 7, 2025
The three-year health tech initiative focuses on designing devices for time-dependent factors like bodily movement, tissue repair, and age-related degeneration.
Researchers at the University of Birmingham and Imperial College London have launched a groundbreaking initiative to revolutionize medical device manufacturing through the 4D Health Tech project.
The three-year health tech initiative focuses on designing devices that can respond to time-dependent factors such as bodily movement, tissue repair, and age-related degeneration.
The project seeks to enhance device functionality and longevity by integrating controlled-degrading materials that support faster healing. It will also incorporate new design methodologies, manufacturing techniques, and patient-specific testing to create medical solutions tailored to diverse populations.
Time-related changes are often overlooked in medical device engineering. For example, pediatric implants require replacement as children grow, and bone implants may degrade faster than regenerating tissue.
Addressing these challenges by incorporating time as a "fourth dimension" could lead to more effective devices, prolong their lifespan, improve patient outcomes, and help manage NHS healthcare expenses.
Sophie Cox, project lead at the University of Birmingham, said, “Our bodies change over time as we grow, move, and regenerate, but products designed to replace or repair our bodies typically neglect the dimension of time, compromising their function and lifespan. Our vision is to transform the way we engineer medical devices.”
The initiative, funded with £1.2 million from the UK Research and Innovation (UKRI) Engineering and Physical Sciences Research Council (EPSRC), is part of a broader £10 million UKRI investment aimed at tackling long-term engineering priorities identified in the Tomorrow’s Engineering Research Challenges (TERC) report.
The initiative aligns with a growing emphasis on innovation in medical technology. In February 2025, the National Institute for Health and Care Excellence (NICE) announced a consultation on changes to its Health Tech program, which could facilitate the adoption of more advanced healthcare technologies within the NHS.
Additionally, in January 2025, the Medicines and Healthcare Products Regulatory Agency (MHRA) released updated guidelines to help medical device manufacturers prepare for new post-market surveillance (PMS) regulations, set to take effect on June 16, 2025.